Publisher： Bentham Science Publishers
E-ISSN： 2212-3873|17|2|114-124
ISSN： 1871-5303
Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.17, Iss.2, 2017-09, pp. : 114-124
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Role of AGEs in Diabetic Nephropathy
Current Pharmaceutical Design, Vol. 14, Iss. 10, 2008-04 ,pp. :
Access to resources
Recommend
By Wylie Emma C Satchell Simon C
Clinical Medicine, Vol. 12, Iss. 5, 2012-10 ,pp. :
The Role of Sulodexide in the Treatment of Diabetic Nephropathy
By Weiss Ram
Drugs, Vol. 67, Iss. 18, 2007-01 ,pp. :
The Podocyte: a Potential Therapeutic Target in Diabetic Nephropathy?
Current Pharmaceutical Design, Vol. 13, Iss. 26, 2007-09 ,pp. :
Irbesartan: A Review of its Use in Hypertension and Diabetic Nephropathy
By Croom Katherine F. Plosker Greg L.
Drugs, Vol. 68, Iss. 11, 2008-01 ,pp. :